Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients.
Dr. Martin Edwards
Novo Holdings A/S
Chief Investment Officer
Vivo Capital Fund VIII, L.P./
Vivo Capital Surplus Fund VIII, L.P.
Dr. Aaron Royston
venBio Global Strategic Fund II, L.P.
Dr. Andreas Wicki
HBM Healthcare Investments (Cayman) Ltd
Executive Advisor and
Former CFO of Abbott